(MENAFN - Investors Ideas) November 21, 2017 (Investorideas.com Newswire) The common shares of Choom Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at .
Choom Holdings, together with its wholly-owned subsidiary, Medi-Can Health Solutions Ltd., a cannabis production license applicant under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR), intends to develop a unique lifestyle brand for cannabis for Canada's emerging cannabis market.
____________________
L'inscription à la cote de CSE des actions ordinaires de Choom Holdings Inc. a été approuvée.
Les documents d'inscription et de divulgation seront disponibles sur www.thecse.com.
Choom Holdings, avec sa filiale en propriété exclusive, Medi-Can Health Solutions Ltd., demande un permis de production de cannabis en vertu du Règlement sur l'accès au cannabis à des fins médicales (ACMPR) de Santé Canada, vise à développer une marque unique pour le cannabis. marché du cannabis.
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:
Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse:
About the CSE
The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets.
Investorideas.com is a listed service provider on the Canadian Securities Exchange
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: . Global investors must adhere to regulations of each country.
MENAFN2111201701420000ID1096126012
